Last reviewed · How we verify

NCT03389373

Microbial Testing for Caries Risk Assessment

Withdrawn NA Last updated 16 July 2018
What this trial tests

NA trial testing GC Strep Mutans Saliva Sampling in Dental Caries. Withdrawn.

Timeline
1 February 2018
Primary endpoint
1 July 2018
1 July 2018

Quick facts

Lead sponsorUniversity of Colorado, Denver
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Start date1 February 2018
Primary completion1 July 2018
Estimated completion1 July 2018
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

University of Colorado, Denver

Who can join

Adults 24 Months to 96 Months, any sex, with Dental Caries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Specific Aims 1\) Assess CG (Cariogenic) Saliva-Check Mutans® saliva testing for identification of high caries risk patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Dental Caries

Currently open trials in the same condition.

Other University of Colorado, Denver trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03389373.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing